Ipca Laboratories, 524494, IPCALAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

26,828.59
29.07
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

27,129.50
0.24%
6.53

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.30
10.01
12.34

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.11
26.61
15.04

PAT CAGR (%)

10 Years
5 Years
3 Years

8.86
44.84
36.03

P:E (Median)

8 Years
5 Years
3 Years

32.35
37.21
35.14

P:BV (Average)

8 Years
5 Years
3 Years

4.17
3.69
4.04

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.71
19.52
19.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 1,485.25 1,011.01 46.91% 1,004.79 833.81 20.51% 1,139.07 947.59 20.21% 1,212.56 997.82 21.52%
Expenses 897.30 815.97 9.97% 812.07 659.14 23.20% 873.63 715.89 22.03% 951.00 825.03 15.27%
EBITDA 587.95 195.04 201.45% 192.72 174.67 10.33% 265.44 231.70 14.56% 261.56 172.79 51.37%
EBIDTM 39.59% 19.29% -0.29% 20.95% 23.30% 24.45% 21.57% 17.32%
Other Income 11.69 19.43 -39.84% 13.30 14.58 -8.78% 17.63 12.63 39.59% 14.33 13.75 4.22%
Interest 2.46 4.47 -44.97% 3.47 6.25 -44.48% 3.80 4.93 -22.92% 4.05 2.38 70.17%
Depreciation 45.23 42.04 7.59% 45.38 41.61 9.06% 46.16 42.62 8.31% 45.11 43.16 4.52%
PBT 551.94 167.96 228.61% 157.17 141.39 11.16% 233.11 196.78 18.46% 226.73 141.00 60.80%
Tax 98.30 35.91 173.74% 29.41 31.92 -7.86% 36.48 36.60 -0.33% 30.71 21.26 44.45%
PAT 453.64 132.05 243.54% 127.76 109.47 16.71% 196.63 160.18 22.76% 196.02 119.74 63.70%
PATM 30.54% 13.06% 2.87% 13.13% 17.26% 16.90% 16.17% 12.00%
EPS 35.89 10.45 243.44% 10.11 8.66 16.74% 15.56 12.67 22.81% 15.51 9.47 63.78%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 1,534.40 1,078.19 42.31% 1,073.76 879.61 22.07% 1,212.86 1,006.14 20.55% 1,283.90 1,012.00 26.87%
Expenses 946.08 879.47 7.57% 905.28 715.03 26.61% 939.20 771.68 21.71% 1,018.04 837.71 21.53%
EBITDA 588.32 198.72 196.05% 168.48 164.58 2.37% 273.66 234.46 16.72% 265.86 174.29 52.54%
EBIDTM 38.34% 18.43% 14.01% 18.71% 22.56% 23.30% 20.71% 17.22%
Other Income 12.09 20.34 -40.56% 13.73 15.26 -10.03% 18.13 13.34 35.91% 14.80 14.76 0.27%
Interest 2.74 4.59 -40.31% 3.67 6.44 -43.01% 4.01 5.12 -21.68% 4.23 2.38 77.73%
Depreciation 51.03 46.10 10.69% 63.94 44.76 42.85% 50.83 45.74 11.13% 49.63 45.35 9.44%
PBT 546.64 168.37 224.67% 114.60 128.64 -10.91% 236.95 196.94 20.32% 226.80 141.32 60.49%
Tax 99.89 37.35 167.44% 29.20 31.65 -7.74% 36.89 37.42 -1.42% 31.89 22.10 44.30%
PAT 446.75 131.02 240.98% 85.40 96.99 -11.95% 200.06 159.52 25.41% 194.91 119.22 63.49%
PATM 29.12% 12.15% 7.11% 11.03% 16.49% 15.85% 15.18% 11.78%
EPS 35.34 10.37 240.79% 6.76 7.67 -11.86% 15.83 12.62 25.44% 15.42 9.43 63.52%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 4,841.67 4,337.82 3,605.66 3,193.40 3,102.21 2,843.06 3,087.84 3,234.82 2,771.24 2,326.60 1,879.18 Net Sales Growth 27.74% 20.31% 12.91% 2.94% 9.12% -7.93% -4.54% 16.73% 19.11% 23.81% Cost Of Goods Sold 1,697.75 1,292.23 1,010.36 966.04 936.63 891.24 956.40 953.85 949.52 795.06 671.67 Gross Profit 3,143.92 3,045.59 2,595.30 2,227.36 2,165.58 1,951.82 2,131.44 2,280.97 1,821.72 1,531.54 1,207.51 GP Margin 64.93% 70.21% 71.98% 69.75% 69.81% 68.65% 69.03% 70.51% 65.74% 65.83% 64.26% Total Expenditure 3,534.00 3,439.48 2,926.87 2,766.48 2,703.54 2,585.54 2,582.48 2,528.38 2,236.09 1,899.28 1,537.94 Power & Fuel Cost - 196.82 175.25 159.89 148.93 140.03 133.39 125.94 103.36 82.94 58.95 % Of Sales - 4.54% 4.86% 5.01% 4.80% 4.93% 4.32% 3.89% 3.73% 3.56% 3.14% Employee Cost - 870.79 752.24 712.78 674.93 603.35 541.22 477.86 376.57 322.20 261.59 % Of Sales - 20.07% 20.86% 22.32% 21.76% 21.22% 17.53% 14.77% 13.59% 13.85% 13.92% Manufacturing Exp. - 449.83 363.05 359.41 400.11 380.86 437.27 412.77 328.81 273.66 238.04 % Of Sales - 10.37% 10.07% 11.25% 12.90% 13.40% 14.16% 12.76% 11.87% 11.76% 12.67% General & Admin Exp. - 233.95 261.02 262.26 237.93 277.90 239.23 245.82 196.76 169.91 132.35 % Of Sales - 5.39% 7.24% 8.21% 7.67% 9.77% 7.75% 7.60% 7.10% 7.30% 7.04% Selling & Distn. Exp. - 355.23 317.80 275.05 281.33 226.94 248.38 234.50 213.47 197.27 170.96 % Of Sales - 8.19% 8.81% 8.61% 9.07% 7.98% 8.04% 7.25% 7.70% 8.48% 9.10% Miscellaneous Exp. - 40.63 47.15 31.05 23.68 65.22 26.59 77.64 67.60 58.24 170.96 % Of Sales - 0.94% 1.31% 0.97% 0.76% 2.29% 0.86% 2.40% 2.44% 2.50% 0.23% EBITDA 1,307.67 898.34 678.79 426.92 398.67 257.52 505.36 706.44 535.15 427.32 341.24 EBITDA Margin 27.01% 20.71% 18.83% 13.37% 12.85% 9.06% 16.37% 21.84% 19.31% 18.37% 18.16% Other Income 56.95 84.16 71.57 57.70 56.52 46.27 58.65 51.14 44.23 49.16 89.03 Interest 13.78 18.84 21.09 27.46 25.99 31.11 29.11 27.60 34.01 42.23 31.14 Depreciation 181.88 178.69 171.88 174.36 171.00 161.23 177.17 100.89 84.00 65.31 55.43 PBT 1,168.95 784.97 557.39 282.80 258.20 111.45 357.73 629.09 461.37 368.94 343.70 Tax 194.90 132.51 102.48 49.69 69.91 18.93 101.62 151.72 129.98 88.77 78.37 Tax Rate 16.67% 16.88% 18.39% 17.57% 27.08% 16.99% 28.41% 24.12% 28.17% 24.06% 23.48% PAT 974.05 652.46 454.91 233.11 188.29 92.52 256.11 477.37 331.39 280.17 255.37 PAT before Minority Interest 974.05 652.46 454.91 233.11 188.29 92.52 256.11 477.37 331.39 280.17 255.37 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.12% 15.04% 12.62% 7.30% 6.07% 3.25% 8.29% 14.76% 11.96% 12.04% 13.59% PAT Growth 86.80% 43.43% 95.15% 23.80% 103.51% -63.87% -46.35% 44.05% 18.28% 9.71% EPS 77.06 51.62 35.99 18.44 14.90 7.32 20.26 37.77 26.22 22.17 20.20

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 5,104.92 4,619.03 3,745.69 3,257.76 3,156.19 2,867.11 3,144.40 3,281.77 2,805.94 2,355.96 1,897.88 Net Sales Growth 28.40% 23.32% 14.98% 3.22% 10.08% -8.82% -4.19% 16.96% 19.10% 24.14% Cost Of Goods Sold 5,949.28 1,455.41 1,090.34 978.34 939.40 903.04 968.00 963.06 955.10 800.91 680.51 Gross Profit -844.36 3,163.62 2,655.35 2,279.42 2,216.79 1,964.07 2,176.40 2,318.71 1,850.84 1,555.05 1,217.37 GP Margin -16.54% 68.49% 70.89% 69.97% 70.24% 68.50% 69.22% 70.65% 65.96% 66.00% 64.14% Total Expenditure 3,808.60 3,728.56 3,067.42 2,815.78 2,740.77 2,593.42 2,630.33 2,569.79 2,268.34 1,928.47 1,558.05 Power & Fuel Cost - 201.22 176.50 161.92 151.00 141.67 135.94 127.91 104.79 83.78 59.18 % Of Sales - 4.36% 4.71% 4.97% 4.78% 4.94% 4.32% 3.90% 3.73% 3.56% 3.12% Employee Cost - 921.23 787.40 735.88 695.98 625.58 566.70 497.99 391.79 335.49 266.28 % Of Sales - 19.94% 21.02% 22.59% 22.05% 21.82% 18.02% 15.17% 13.96% 14.24% 14.03% Manufacturing Exp. - 471.80 374.26 366.92 404.52 387.75 439.11 415.69 331.73 275.82 238.31 % Of Sales - 10.21% 9.99% 11.26% 12.82% 13.52% 13.96% 12.67% 11.82% 11.71% 12.56% General & Admin Exp. - 249.90 271.85 268.52 246.68 245.42 246.73 255.40 205.02 178.12 139.13 % Of Sales - 5.41% 7.26% 8.24% 7.82% 8.56% 7.85% 7.78% 7.31% 7.56% 7.33% Selling & Distn. Exp. - 359.15 324.77 277.62 280.74 223.67 245.00 231.18 212.94 196.09 169.91 % Of Sales - 7.78% 8.67% 8.52% 8.89% 7.80% 7.79% 7.04% 7.59% 8.32% 8.95% Miscellaneous Exp. - 69.85 42.30 26.58 22.45 66.29 28.85 78.56 66.97 58.26 169.91 % Of Sales - 1.51% 1.13% 0.82% 0.71% 2.31% 0.92% 2.39% 2.39% 2.47% 0.25% EBITDA 1,296.32 890.47 678.27 441.98 415.42 273.69 514.07 711.98 537.60 427.49 339.83 EBITDA Margin 25.39% 19.28% 18.11% 13.57% 13.16% 9.55% 16.35% 21.69% 19.16% 18.15% 17.91% Other Income 58.75 86.50 74.66 58.08 54.76 40.77 58.69 51.97 39.88 48.34 89.00 Interest 14.65 19.77 22.24 27.57 26.91 34.56 32.13 30.23 36.48 44.39 32.35 Depreciation 215.43 210.50 182.42 177.73 172.95 163.26 179.55 103.13 86.73 67.13 55.79 PBT 1,124.99 746.70 548.27 294.76 270.32 116.64 361.08 630.59 454.27 364.31 340.69 Tax 197.87 135.33 104.24 51.11 67.52 20.44 101.93 152.39 129.94 88.11 78.38 Tax Rate 17.59% 18.12% 19.01% 17.34% 24.98% 17.52% 28.23% 24.17% 28.60% 24.19% 23.01% PAT 927.12 613.28 447.39 243.65 202.80 96.20 259.15 478.20 324.33 276.20 262.39 PAT before Minority Interest 927.17 611.37 444.03 243.65 202.80 96.20 259.15 478.20 324.33 276.20 262.31 Minority Interest 0.05 1.91 3.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 PAT Margin 18.16% 13.28% 11.94% 7.48% 6.43% 3.36% 8.24% 14.57% 11.56% 11.72% 13.83% PAT Growth 82.95% 37.08% 83.62% 20.14% 110.81% -62.88% -45.81% 47.44% 17.43% 5.26% EPS 73.35 48.52 35.39 19.28 16.04 7.61 20.50 37.83 25.66 21.85 20.76

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3,677.54 3,136.66 2,694.94 2,475.12 2,283.05 2,233.33 1,981.61 1,569.85 1,262.27 1,053.86 Share Capital 25.27 25.27 25.24 25.24 25.24 25.24 25.24 25.24 25.17 25.14 Total Reserves 3,640.33 3,111.39 2,669.38 2,449.88 2,257.81 2,208.09 1,956.37 1,544.61 1,236.96 1,028.24 Non-Current Liabilities 265.43 307.04 420.11 546.49 661.70 696.75 456.21 509.21 432.58 282.35 Secured Loans 64.21 133.94 234.01 347.22 433.63 447.65 292.12 366.21 330.18 194.62 Unsecured Loans 14.17 0.00 0.00 4.52 50.65 53.75 0.00 0.00 0.00 0.00 Long Term Provisions 30.98 25.28 25.88 24.55 20.22 17.91 14.49 12.21 8.72 5.34 Current Liabilities 1,241.60 1,013.84 992.65 946.34 959.88 894.16 779.55 629.69 635.20 576.95 Trade Payables 537.85 464.09 414.75 388.06 415.24 302.56 337.05 265.46 230.71 177.05 Other Current Liabilities 294.88 266.94 262.00 315.35 296.09 234.93 249.82 165.18 174.56 99.89 Short Term Borrowings 309.27 195.86 239.04 177.30 182.86 320.98 137.96 157.14 201.36 263.35 Short Term Provisions 99.60 86.95 76.86 65.63 65.69 35.69 54.72 41.91 28.57 36.66 Total Liabilities 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 3,824.24 3,217.37 2,708.75 2,330.05 1,913.16 Net Block 1,840.97 1,740.10 1,854.61 1,945.97 1,976.58 1,752.96 1,306.11 1,075.33 912.82 697.82 Gross Block 2,679.08 2,412.97 2,358.72 2,276.99 2,137.32 2,465.90 1,851.29 1,524.85 1,284.51 985.58 Accumulated Depreciation 838.11 672.87 504.11 331.02 160.74 712.94 545.18 449.52 371.69 287.76 Non Current Assets 2,472.46 2,171.99 2,200.54 2,256.30 2,304.86 2,230.93 1,634.73 1,323.95 1,133.47 881.28 Capital Work in Progress 84.19 65.96 73.23 94.87 128.93 266.95 164.90 129.17 94.51 94.75 Non Current Investment 410.47 231.86 146.28 98.01 97.43 81.86 28.75 21.79 42.65 48.79 Long Term Loans & Adv. 123.30 126.74 115.80 103.53 79.61 118.33 125.12 87.77 76.13 36.98 Other Non Current Assets 13.53 7.33 10.62 13.92 22.31 10.83 9.85 9.89 7.36 2.94 Current Assets 2,712.11 2,285.55 1,907.16 1,711.65 1,599.77 1,593.31 1,582.64 1,384.80 1,196.58 1,031.88 Current Investments 238.25 90.38 69.35 113.57 0.00 0.00 0.15 0.15 0.15 0.15 Inventories 1,266.96 1,055.55 873.17 873.54 831.93 916.98 838.30 733.34 663.98 462.51 Sundry Debtors 839.13 632.06 594.38 501.98 441.45 353.55 448.76 415.93 340.91 369.87 Cash & Bank 152.40 259.81 131.03 17.53 161.98 113.19 69.22 54.66 9.25 8.44 Other Current Assets 215.37 216.76 225.55 189.43 164.41 209.59 226.21 180.72 182.29 190.91 Short Term Loans & Adv. 22.52 30.99 13.68 15.60 19.72 37.03 53.58 40.26 27.41 55.84 Net Current Assets 1,470.51 1,271.71 914.51 765.31 639.89 699.15 803.09 755.11 561.38 454.93 Total Assets 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 3,824.24 3,217.37 2,708.75 2,330.05 1,913.16

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3,627.48 3,122.39 2,688.57 2,455.26 2,259.19 2,208.43 1,959.66 1,553.78 1,254.01 1,051.59 Share Capital 25.27 25.27 25.24 25.24 25.24 25.24 25.24 25.24 25.17 25.14 Total Reserves 3,590.27 3,097.12 2,663.01 2,430.02 2,233.95 2,183.19 1,934.42 1,528.54 1,228.70 1,025.97 Non-Current Liabilities 290.29 313.40 419.42 548.32 662.57 699.57 459.45 509.52 433.15 282.35 Secured Loans 88.80 133.94 234.01 347.22 433.63 447.65 292.12 366.21 330.18 194.62 Unsecured Loans 14.17 6.91 0.00 4.52 50.64 55.56 1.88 0.00 0.00 0.00 Long Term Provisions 32.23 25.28 25.88 24.55 20.22 18.03 14.93 12.21 8.72 5.34 Current Liabilities 1,326.42 1,097.50 1,007.57 955.93 969.95 904.36 791.45 633.65 640.17 578.53 Trade Payables 609.85 524.32 423.47 396.54 421.11 306.59 340.99 268.37 234.52 178.55 Other Current Liabilities 304.57 274.74 266.75 316.41 297.50 236.44 250.88 166.00 175.33 99.97 Short Term Borrowings 310.95 209.69 239.04 177.30 184.85 325.35 143.94 157.14 201.36 263.35 Short Term Provisions 101.05 88.75 78.31 65.68 66.49 35.98 55.64 42.14 28.96 36.66 Total Liabilities 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 3,812.36 3,210.56 2,696.95 2,327.33 1,911.81 Net Block 2,106.79 1,940.38 1,952.96 1,983.27 2,014.18 1,800.43 1,353.59 1,104.23 944.08 699.22 Gross Block 3,033.79 2,632.86 2,464.33 2,318.22 2,176.95 2,546.33 1,932.05 1,579.07 1,338.55 988.42 Accumulated Depreciation 927.00 692.48 511.37 334.95 162.77 745.90 578.46 474.84 394.47 289.20 Non Current Assets 2,402.11 2,171.08 2,170.08 2,217.69 2,269.79 2,198.38 1,609.14 1,299.78 1,117.30 875.01 Capital Work in Progress 85.22 66.33 73.00 94.64 128.74 267.22 164.90 129.17 94.51 94.75 Non Current Investment 71.31 30.05 17.52 22.24 25.82 16.19 9.00 8.87 33.93 40.68 Long Term Loans & Adv. 124.68 126.82 115.83 103.58 78.44 103.47 71.26 47.49 37.12 37.07 Other Non Current Assets 14.11 7.50 10.77 13.96 22.61 11.07 10.39 10.02 7.66 3.29 Current Assets 2,855.71 2,377.75 1,945.48 1,741.82 1,621.92 1,613.98 1,601.42 1,397.17 1,210.03 1,036.80 Current Investments 238.25 90.38 69.35 113.57 0.00 0.00 0.15 0.15 0.15 0.15 Inventories 1,323.12 1,072.50 880.59 882.22 837.42 926.56 847.58 741.03 669.89 466.40 Sundry Debtors 895.20 681.51 602.27 500.16 445.87 353.00 449.79 417.81 344.88 367.21 Cash & Bank 180.92 282.30 150.57 35.85 175.54 124.79 76.01 58.24 12.16 10.36 Other Current Assets 218.22 219.62 228.26 194.46 163.09 209.63 227.89 179.94 182.95 192.68 Short Term Loans & Adv. 22.30 31.44 14.44 15.56 17.31 36.19 53.84 31.22 27.73 56.71 Net Current Assets 1,529.29 1,280.25 937.91 785.89 651.97 709.62 809.97 763.52 569.86 458.27 Total Assets 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 3,812.36 3,210.56 2,696.95 2,327.33 1,911.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 554.35 486.90 323.86 271.14 696.00 455.34 514.78 386.85 318.84 214.57 PBT 784.97 557.39 282.80 258.20 111.45 357.73 629.09 461.37 368.94 343.70 Adjustment 174.69 166.04 185.03 161.82 201.27 182.03 134.36 117.23 152.12 37.06 Changes in Working Capital -258.90 -128.87 -86.56 -94.56 412.34 -9.96 -118.48 -100.02 -122.32 -102.16 Cash after chg. in Working capital 700.76 594.56 381.27 325.46 725.06 529.80 644.97 478.58 398.74 278.60 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -146.41 -107.66 -57.41 -54.32 -29.06 -74.46 -130.19 -91.73 -79.90 -64.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -498.13 -114.23 -119.34 -145.55 -213.62 -685.71 -362.07 -260.92 -251.45 -198.84 Net Fixed Assets -284.34 -46.98 -60.09 -105.61 466.60 -716.66 -362.17 -275.00 -298.69 -163.58 Net Investments -326.48 -106.61 -4.05 -114.15 -15.57 -52.96 -6.96 20.86 6.14 0.48 Others 112.69 39.36 -55.20 74.21 -664.65 83.91 7.06 -6.78 41.10 -35.74 Cash from Financing Activity -132.59 -222.83 -130.43 -156.39 -414.16 254.99 -138.36 -80.63 -69.02 -16.80 Net Cash Inflow / Outflow -76.37 149.84 74.09 -30.80 68.22 24.62 14.35 45.30 -1.63 -1.07 Opening Cash & Equivalents 348.44 198.60 124.51 155.31 87.09 67.46 53.11 7.81 7.22 8.29 Closing Cash & Equivalent 272.07 348.44 198.60 124.51 155.31 92.08 67.46 53.11 7.81 7.22

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 564.27 492.28 341.13 281.91 708.65 455.29 522.29 388.77 353.84 214.20 PBT 738.89 546.46 290.53 262.06 116.64 361.08 630.59 454.27 364.31 340.69 Adjustment 241.29 178.61 192.51 174.86 211.11 187.91 139.92 126.16 156.99 39.13 Changes in Working Capital -263.69 -121.97 -84.44 -103.73 410.30 -18.68 -117.72 -100.10 -87.39 -101.25 Cash after chg. in Working capital 716.49 603.10 398.60 333.19 738.05 530.31 652.79 480.33 433.91 278.57 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -152.22 -110.82 -57.47 -51.28 -29.40 -75.02 -130.50 -91.56 -80.07 -64.37 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -509.65 -156.31 -135.40 -148.82 -218.33 -676.40 -369.01 -259.87 -285.90 -198.10 Net Fixed Assets -284.34 -46.98 -60.09 -105.61 466.60 -716.66 -362.17 -275.00 -298.69 -163.58 Net Investments -326.48 -106.61 -4.05 -114.15 -15.57 -52.96 -6.96 20.86 6.14 0.48 Others 101.17 -2.72 -71.26 70.94 -669.36 93.22 0.12 -5.73 6.65 -35.00 Cash from Financing Activity -130.46 -183.20 -130.41 -159.13 -461.51 250.54 -136.13 -82.93 -71.81 -17.75 Net Cash Inflow / Outflow -75.84 152.77 75.32 -26.04 28.81 29.43 17.15 45.97 -3.87 -1.65 Opening Cash & Equivalents 370.92 218.15 142.83 168.87 140.06 74.25 56.69 10.72 9.14 10.79 Closing Cash & Equivalent 295.39 370.92 218.15 142.83 168.87 103.68 74.25 56.69 10.72 9.14

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 290.11 248.25 213.52 196.13 180.91 176.97 157.02 124.39 100.29 83.80 ROA 13.53% 10.62% 5.77% 4.78% 2.39% 7.27% 16.11% 13.15% 13.21% 14.45% ROE 19.18% 15.60% 9.02% 7.91% 4.10% 12.15% 26.88% 23.40% 24.20% 26.51% ROCE 20.84% 16.76% 9.53% 8.97% 4.52% 13.48% 27.57% 24.46% 23.86% 25.05% Fixed Asset Turnover 1.72 1.52 1.39 1.43 1.24 1.45 1.94 2.00 2.07 2.03 Receivable days 61.48 61.61 62.15 54.52 51.03 46.94 48.31 49.28 55.23 73.41 Inventory Days 97.05 96.88 99.02 98.55 112.26 102.68 87.80 90.97 87.53 80.30 Payable days 47.09 49.40 50.05 51.96 52.98 39.18 36.44 31.15 30.32 25.40 Cash Conversion Cycle 111.44 109.09 111.12 101.10 110.31 110.44 99.66 109.10 112.44 128.31 Total Debt/Equity 0.12 0.14 0.23 0.29 0.38 0.42 0.30 0.39 0.48 0.50 Interest Cover 42.67 27.43 11.30 10.93 4.58 13.29 23.79 14.57 9.74 11.72

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 286.15 247.12 213.02 194.55 179.02 174.99 155.28 123.12 99.63 83.62 ROA 12.47% 10.25% 6.03% 5.17% 2.50% 7.38% 16.19% 12.91% 13.03% 14.88% ROE 18.15% 15.28% 9.47% 8.60% 4.31% 12.43% 27.22% 23.10% 23.97% 27.41% ROCE 19.92% 16.53% 9.94% 9.44% 4.82% 13.78% 27.92% 24.38% 23.78% 25.72% Fixed Asset Turnover 1.64 1.48 1.37 1.43 1.23 1.42 1.89 1.95 2.04 2.05 Receivable days 61.90 62.09 61.27 53.75 50.16 46.12 47.78 49.05 54.65 72.06 Inventory Days 94.05 94.47 97.98 97.70 110.76 101.93 87.49 90.74 87.21 80.79 Payable days 49.85 51.02 50.35 52.23 52.92 39.11 36.45 31.30 30.47 25.50 Cash Conversion Cycle 106.10 105.54 108.90 99.22 108.00 108.95 98.82 108.49 111.38 127.35 Total Debt/Equity 0.13 0.15 0.23 0.29 0.38 0.42 0.31 0.40 0.48 0.50 Interest Cover 38.77 25.65 11.69 11.05 4.38 12.24 21.86 13.45 9.21 11.53

Top Investors:

dsp small cap fund

hdfc trustee company ltd - a/c hdfc mid - capopportunities fund

l and t mutual fund trustee ltd-l and t mid cap fund

axis mutual fund trustee limited a/c axis mutual fund a/c axis midcap fund

hdfc life insurance company limited

uti- equity fund

idfc sterling value fund

sbi life insurance co. ltd

canara robeco mutual fund a/c canara robeco emerging equities

iepf

Annual Reports:

News Update:

Ipca Laboratories in process of obtaining environmental clearance for new plant in MP
17th Aug 2020, 11:39 AM

The company has already acquired land for the project
Read More
Ipca Laboratories - Quarterly Results
10th Aug 2020, 13:37 PM

Read More

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524494 | NSE: IPCALAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524494 | NSE: IPCALAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: